Kamal Mubarak, MD
Pulmonary Disease · Bismarck, NDNPI 1619914108
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,298 of the $1,569 with a category attached, or 82.7%. Olympus Corporation Of The Americas accounts for 86.1% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $928, more than ten times the $36 reported in 2023. That places this record below the midpoint for pulmonary disease clinicians in ND, where the typical reported total is $2,980.
Across 18 payments — averaging $87.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus Corporation Of The Americas$1K
- Harmony Biosciences LLC$42
- Insmed, Inc.$33
- QOL Medical, LLC$23
- Baxter Healthcare$23
- UCB, Inc.$19
- plus $79 from 5 others
What the payments were for
- Travel & lodging$1,29883%
- Food & beverage$27117%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus Corporation Of The Americas | 6 | $1,351 |
| Harmony Biosciences LLC | 2 | $42 |
| Insmed, Inc. | 2 | $33 |
| QOL Medical, LLC | 1 | $23 |
| Baxter Healthcare | 1 | $23 |
| UCB, Inc. | 1 | $19 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| AstraZeneca | 1 | $16 |
| Viatris Specialty LLC | 1 | $14 |
| Boehringer Ingelheim | 1 | $14 |
How this compares
$1,569 in reported general payments places this provider in the 35th percentile of 31 pulmonary disease providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Bismarck
- Alfredo IardinoBismarck$26K
- Haven MalishBismarck$16K
- Bhaja ShresthaBismarck$10K
- Saurav PokharelBismarck$5K
- Nameer Al YousifBismarck$5K
- Marwan MashinaBismarck$3K
- Eusebio DesuyoBismarck$2K
- Andreas SarrigiannidisBismarck$1K
- Monica PauloBismarck$118
- Shaher SamrahBismarck$92
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.